<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hemoglobinopathies and Aplastic Anemia</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\(', '\)']],
            displayMath: [['$$', '$$'], ['\[', '\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hematology-introduction-anemia.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33.33%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 6</span> <!-- Update text -->
                    </div>
                    <a href="hematology-hemostasis-coagulation.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Hemoglobin and Hemoglobinopathies</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: hemoglobinopathies -->
                <section id="hemoglobinopathies" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">HEMOGLOBIN AND HEMOGLOBINOPATHIES</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Hemoglobin Structure and Production</h3>
                        <ul>
                            <li>4 $\alpha$ genes are located on chromosome 16</li>
                            <li>2 $\beta$ genes are located on chromosome 11</li>
                            <li>heme group in centre with iron</li>
                            <li>fetal hemoglobin, HbF(O2) switches to adult forms HbA($\beta$2) and HbA2($\delta$2) at 3-6 months of life</li>
                            <li>HbA constitutes 97% of adult hemoglobin</li>
                            <li>HbA2 constitutes 3% of adult hemoglobin</li>
                            <li>beware of the possibility of mixed defects e.g. $\beta$-thalessemia minor and sickle cell trait</li>
                        </ul>
                    </div>
                </section>
                <!-- END: hemoglobinopathies -->

                <!-- START: thalassemia -->
                <section id="thalassemia" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">THALASSEMIA</span>
                    </h2>
                    <div class="content-card">
                        <p>defects in production of Hb $\beta$ that leads to microcytosis</p>
                        <h3 class="subsection-heading">I. HETEROZYGOUS: $\beta$-Thalassemia Minor</h3>
                        <p>common among people of Mediterranean and Asian descent</p>
                        <h4>Clinical Presentation</h4>
                        <ul>
                            <li>depends on extent of disease</li>
                            <li>mild or no anemia</li>
                            <li>possible palpable spleen</li>
                            <li>may be masked by Fe deficiency</li>
                        </ul>
                        <h4>Diagnosis</h4>
                        <ul>
                            <li><strong>serum</strong>
                                <ul><li>Hb 90-140 g/L, MCV &lt; 70</li></ul>
                            </li>
                            <li><strong>peripheral blood</strong>
                                <ul>
                                    <li>microcytosis +/- hypochromia</li>
                                    <li>target cells and increased poikilocytosis ("fish RBC") may be present</li>
                                    <li>basophilic stippling usually present</li>
                                </ul>
                            </li>
                            <li><strong>Hb electrophoresis</strong>
                                <ul>
                                    <li>specific: Hb A2 increased to 0.025-0.05 (2.5-5%) (normal 1.5-3.5%)</li>
                                    <li>non-specific: 50% have slight increase in HbF</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Management</h4>
                        <ul>
                            <li>not necessary to treat</li>
                            <li>patient and family should receive genetic counselling</li>
                        </ul>

                        <h3 class="subsection-heading">II. HOMOZYGOUS: $\beta$-Thalassemia Major</h3>
                        <h4>Pathophysiology</h4>
                        <ul>
                            <li>autosomal recessive</li>
                            <li>ineffective chain synthesis leading to ineffective erythropoiesis and hemolysis of RBC</li>
                            <li>increase in HbF</li>
                        </ul>
                        <h4>Clinical Presentation</h4>
                        <ul>
                            <li>initial presentation at 3-6 months due to replacement of HbF by HbA</li>
                            <li>severe anemia develops in the first year of life</li>
                            <li>jaundice</li>
                            <li>stunted growth and development (hypogonadal dwarf)</li>
                            <li>gross hepatosplenomegaly (extramedullary hematopoiesis)</li>
                            <li>changes (expanded marrow cavity)
                                <ul>
                                    <li>skull x-ray has "hair-on-end" appearance</li>
                                    <li>pathological fractures common</li>
                                </ul>
                            </li>
                            <li>evidence of increased Hb catabolism (e.g. gallstones)</li>
                            <li>death from
                                <ul>
                                    <li>untreated anemia (transfuse)</li>
                                    <li>infection (treat early)</li>
                                    <li>hemochromatosis (late, secondary to transfusions), usually 20-30 years old</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Diagnosis</h4>
                        <ul>
                             <li><strong>CBC</strong>
                                <ul><li>hemoglobin 40-60 g/L</li></ul>
                            </li>
                            <li><strong>peripheral blood</strong>
                                <ul>
                                    <li>hypochromic microcytosis</li>
                                    <li>increased reticulocytes</li>
                                    <li>basophilic stippling, target cells</li>
                                    <li>postsplenectomy blood film shows Howell Jolly bodies, erythroblasts, and thrombocytosis</li>
                                </ul>
                            </li>
                            <li><strong>Hb electrophoresis</strong>
                                <ul>
                                    <li>Hb A: 0-0.10 (0-10%) , (normal > 95%)</li>
                                    <li>Hb F: 0.90-1.00 (90-100%)</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Management</h4>
                        <ul>
                            <li>transfusion</li>
                            <li>Fe chelation to prevent iron overload (e.g. desferal)</li>
                            <li>bone marrow transplant</li>
                        </ul>
                        <h3 class="subsection-heading">III. ALPHA THALASSEMIA</h3>
                        <ul>
                            <li>similar distribution to thalassemia but a higher frequency among Asians</li>
                        </ul>
                        <h4>Pathophysiology</h4>
                        <ul>
                            <li>autosomal recessive</li>
                            <li>deficit of $\alpha$ chains</li>
                            <li>4 grades of severity depending on the number of defective alpha genes
                                <ul>
                                    <li>1 - silent</li>
                                    <li>2 - trait</li>
                                    <li>3 - HbH Disease (presents in adults due to excess chain production)</li>
                                    <li>4 - Hb Bart's (hydrops fetalis, not compatible with life)</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Diagnosis</h4>
                        <ul>
                            <li><strong>peripheral blood film</strong>
                                <ul>
                                    <li>microcytes, hypochromia, occasional target cells</li>
                                    <li>screen for HbH inclusion bodies</li>
                                </ul>
                            </li>
                            <li>Hb electrophoresis not diagnostic</li>
                            <li>DNA analysis using alpha gene probe</li>
                        </ul>
                         <h4>Management</h4>
                        <ul>
                            <li>same as $\beta$ thalassemia</li>
                        </ul>
                    </div>
                </section>
                <!-- END: thalassemia -->
                
                <!-- START: sickle-cell-anemia -->
                <section id="sickle-cell-anemia" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">SICKLE CELL ANEMIA</span>
                    </h2>
                    <div class="content-card">
                         <ul>
                            <li>autosomal recessive</li>
                            <li>amino acid substitution of valine for glutamate in position 6 of beta globin chain</li>
                        </ul>
                        <h3 class="subsection-heading">Mechanisms of Sickling (see Figure 1)</h3>
                        <ul>
                            <li>at low pO2, deoxy Hb S polymerizes, leading to rigid crystal-like rods that distort membranes = SICKLES</li>
                            <li>the pO2 level at which sickling occurs is related to the precentage of Hb S present
                                <ul>
                                    <li>in heterozygotes (Hb AS) sickling occurs at a pO2 of 40 mmHg</li>
                                    <li>in homozygous (Hb SS), sickling occurs at a pO2 of 80 mmHg</li>
                                </ul>
                            </li>
                            <li>sickling is aggravated by
                                <ul>
                                    <li>increased H+</li>
                                    <li>increased CO2</li>
                                    <li>increased 2,3-DPG</li>
                                    <li>increased temperature and osmolality</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_09_19_3f788f8fa9a6daaca993g-09-1.jpg" alt="Figure 1: Pathophysiology of Sickle Cell Anemia, showing how deoxygenation leads to HbS polymerization, sickling, and subsequent vaso-occlusion and hemolysis." class="content-image">
                            <figcaption>Figure 1. Mechanisms of Sickling</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Heterozygous: Hb S Trait</h3>
                        <ul>
                            <li><strong>clinical presentation</strong>
                                <ul><li>patient will appear normal except at times of extreme hypoxia and infection</li></ul>
                            </li>
                            <li><strong>diagnosis</strong>
                                <ul>
                                    <li>serum: Hb normal</li>
                                    <li>peripheral blood: normal except for possibly a few target cells</li>
                                    <li>Hb electrophoresis (confirmatory test): Hb A fraction of 0.65 (65%); Hb S fraction of 0.35 (35%)</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Homozygous: Hb S Disease</h3>
                        <ul>
                            <li><strong>clinical presentation</strong>
                                <ul>
                                    <li>chronic hemolytic anemia</li>
                                    <li>jaundice in the first year of life</li>
                                    <li>vaso-occlusive crises (infarction) leading to pain, fever and leukocytosis e.g. acute chest syndrome (pulmonary infarct) associated with infection, such as parvovirus, leading to aplastic anemia, acidosis, dehydration, and hypoxia</li>
                                    <li>susceptibility to infections by encapsulated organisms due to hyposplenism</li>
                                    <li>retarded growth and development +/- skeletal changes</li>
                                    <li>spleen enlarged in child and atrophic in adult</li>
                                </ul>
                            </li>
                            <li><strong>diagnosis</strong>
                                <ul>
                                    <li>peripheral blood: sickled cells (see Colour Atlas H6)</li>
                                    <li>screening test: sickle cell prep</li>
                                    <li>Hb electrophoresis (confirmatory test): Hb S fraction > 0.80</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>prevention of crises is the key
                                <ul>
                                    <li>establish diagnosis</li>
                                    <li>avoid conditions that favor sickling (hypoxia, acidosis, dehydration, fever)</li>
                                    <li>vaccination in childhood e.g. pneumococcus, meningococcus</li>
                                    <li>consider prophylaxis - penicillin V 250 mg PO bid</li>
                                    <li>good hygiene and nutrition</li>
                                </ul>
                            </li>
                            <li>genetic counselling</li>
                            <li>folic acid to avoid folate deficiency</li>
                            <li>hydroxyurea to enhance production of HbF
                                <ul>
                                    <li>causes depression of the gene for HbF or by initiating differentiation of stem cells in which this gene is active; presence of HbF in the SS cells decreases polymerization and precipitation of HbS</li>
                                    <li>Note: hydroxyurea is cytotoxic and may cause bone marrow suppression</li>
                                </ul>
                            </li>
                        </ul>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 5. Organs Affected by Vaso-Occlusive Crisis</caption>
                                <thead>
                                    <tr><th>Organ</th><th>Problem</th></tr>
                                </thead>
                                <tbody>
                                    <tr><td>eye</td><td>seizures, hemiplegia</td></tr>
                                    <tr><td>liver</td><td>infarcts, RUQ syndrome</td></tr>
                                    <tr><td>gall bladder</td><td>stones</td></tr>
                                    <tr><td>heart</td><td>hyperdynamic flow murmurs</td></tr>
                                    <tr><td>kidney</td><td>hematuria; loss of renal concentrating ability</td></tr>
                                    <tr><td>placenta</td><td>stillbirths</td></tr>
                                    <tr><td>penis</td><td>priapism</td></tr>
                                    <tr><td>digits</td><td>dactylitis</td></tr>
                                    <tr><td>femoral head</td><td>aseptic necrosis</td></tr>
                                    <tr><td>bone</td><td>infarction, infection</td></tr>
                                    <tr><td>ankle</td><td>leg ulcers</td></tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">Treatment of Vaso-Occlusive Crisis</h3>
                        <ul>
                            <li>oxygen</li>
                            <li>hydration (reduces viscosity)</li>
                            <li>antimicrobials</li>
                            <li>correct acidosis</li>
                            <li>analgesics/narcotics (give enough)</li>
                            <li>magnesium (inhibits potassium and water efflux from RBCs thereby preventing dehydration)</li>
                            <li>exchange transfusion for CNS crisis</li>
                            <li>experimental anti-sickling agents</li>
                        </ul>
                    </div>
                </section>
                <!-- END: sickle-cell-anemia -->
                
                <!-- START: megaloblastic-anemia -->
                <section id="megaloblastic-anemia" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">MEGALOBLASTIC ANEMIA</span>
                    </h2>
                    <div class="content-card">
                        <p>failure of DNA synthesis resulting in asynchronous maturation of RBC nucleus and cytoplasm non-megaloblastic anemia reflects membrane abnormality with abnormal cholesterol metabolism megaloblast = large, nucleated RBC precursor; macrocyte = large RBC</p>
                        <h3 class="subsection-heading">Causes of Megaloblastosis</h3>
                        <ul>
                            <li>folate deficiency (seen after 4 months of decreased intake)</li>
                            <li>B12 deficiency (seen after 10-15 years decreased intake)</li>
                            <li>antimetabolite drugs
                                <ul>
                                    <li>methotrexate</li>
                                    <li>folate analogues (sulpha drugs)</li>
                                    <li>purine/pyrimidine analogues (6-MP, 5-FU)</li>
                                </ul>
                            </li>
                            <li>nitrous oxide</li>
                            <li>myelodysplasia/some cases of AML</li>
                        </ul>
                    </div>
                </section>
                <!-- END: megaloblastic-anemia -->
                
                <!-- START: b12-deficiency -->
                <section id="b12-deficiency" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">B12 DEFICIENCY</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Etiology</h3>
                        <ul>
                            <li>if intake stops abruptly body stores last 3-4 years</li>
                            <li><strong>diet</strong>
                                <ul><li>strict vegetarian (rare)</li></ul>
                            </li>
                             <li><strong>gastric</strong>
                                <ul>
                                    <li>mucosal atrophy of pernicious anemia</li>
                                    <li>post-gastrectomy</li>
                                </ul>
                            </li>
                             <li><strong>intestinal absorption</strong>
                                <ul>
                                    <li>malabsorption (e.g. Crohn's, celiac sprue, pancreatic disease)</li>
                                    <li>stagnant bowel (e.g. blind loop, stricture)</li>
                                    <li>fish tapeworm</li>
                                    <li>resection of ileum as in Crohn's and celiac sprue</li>
                                </ul>
                            </li>
                            <li>rare genetic causes</li>
                        </ul>
                        <h3 class="subsection-heading">Pernicious Anemia</h3>
                        <ul>
                            <li>auto-antibodies produced against gastric parietal cells leading to achlorhydria and no intrinsic factor secretion
                                <ul>
                                    <li>intrinsic factor is required to stabilize B<sub>12</sub> as it passes through the bowel</li>
                                    <li>decreased intrinsic factor leads to decreased ileal absorption of B<sub>12</sub></li>
                                </ul>
                            </li>
                            <li>female:male = 1.6:1</li>
                            <li>may be associated with other autoimmune disorders e.g. thyroid and adrenal deficiency often > 60 years old</li>
                        </ul>
                        <h3 class="subsection-heading">Neurological Lesions in B12 Deficiency</h3>
                        <ul>
                            <li><strong>cerebral (common; reversible with B12 therapy)</strong>
                                <ul>
                                    <li>confusion</li>
                                    <li>delirium</li>
                                    <li>dementia</li>
                                </ul>
                            </li>
                            <li><strong>cranial nerves</strong>
                                <ul><li>optic atrophy (rare)</li></ul>
                            </li>
                             <li><strong>cord (irreversible damage)</strong>
                                <ul>
                                    <li>subacute combined degeneration</li>
                                    <li>posterior columns - paresthesias, disturbed vibration, decreased proprioception</li>
                                    <li>pyramidal tracts - spastic weakness, hyperactive reflexes</li>
                                </ul>
                            </li>
                             <li><strong>peripheral neuropathy (variable reversibility)</strong>
                                <ul>
                                    <li>usually symmetrical</li>
                                    <li>affecting lower limbs more than upper limbs</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Diagnosis</h3>
                        <ul>
                            <li><strong>serum</strong>
                                <ul>
                                    <li>anemia often severe +/- neutropenia +/- thrombocytopenia</li>
                                    <li>MCV > 120</li>
                                    <li>low reticulocyte count relative to the degree of anemia</li>
                                </ul>
                            </li>
                            <li><strong>serum B12 and RBC folate</strong>
                                <ul><li>caution: low serum B<sub>12</sub> leads to low RBC folate because of failure of folate polyglutamate synthesis in the absence of B<sub>12</sub></li></ul>
                            </li>
                            <li><strong>blood film</strong>
                                <ul>
                                    <li>oval macrocytes (see Colour Atlas H2A)</li>
                                    <li>hypersegmented neutrophils (see Colour Atlas H2B)</li>
                                </ul>
                            </li>
                             <li><strong>bone marrow</strong>
                                <ul>
                                    <li>differentiates between megaloblastic and myelodysplastic anemias</li>
                                    <li>hypercellularity</li>
                                    <li>failure of nuclear maturation</li>
                                    <li>elevated unconjugated bilirubin and LDH due to marrow cell breakdown</li>
                                </ul>
                            </li>
                             <li><strong>Schilling test to distinguish pernicious anemia from other causes</strong>
                                <ul>
                                    <li>Schilling test: part 1
                                        <ul>
                                            <li>tracer dose (1g $\mu$g) of labelled B<sub>12</sub> (cobalamin (Co*)), PO</li>
                                            <li>flushing dose (1 mg) of cold B<sub>12</sub>, IM to saturate tissue binders of B<sub>12</sub> thus allowing radioactive B<sub>12</sub> to be excreted in urine</li>
                                            <li>24 hour urine Co* measured</li>
                                            <li>normal &rarr; 5% excretion</li>
                                        </ul>
                                    </li>
                                     <li>Schilling test: part 2
                                        <ul>
                                            <li>tracer dose B<sub>12</sub>(Co*) plus intrinsic factor, PO</li>
                                            <li>flushing dose of cold B12, injected IM</li>
                                            <li>24 hour urine Co * measured</li>
                                            <li>normal test result (> 5% excretion) = pernicious anemia</li>
                                            <li>abnormal test result (&lt; 5% excretion) = intestinal causes (malabsorption)</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                         <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>B<sub>12</sub> 100 $\mu$g IM monthly for life or oral Bı2</li>
                            <li>watch for hypokalemia (due to return of potassium to intracellular sites) and thrombocythemia</li>
                        </ul>
                    </div>
                </section>
                <!-- END: b12-deficiency -->
                
                <!-- START: folate-deficiency -->
                <section id="folate-deficiency" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">FOLATE DEFICIENCY</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>more common than B12 deficiency because folate stores are depleted in 3-6 months</li>
                            <li>folate complexes with gastric R binder</li>
                            <li>R binder is replaced by intrinsic factor in the duodenum</li>
                            <li>this complex is absorbed in the jejunum</li>
                        </ul>
                        <h3 class="subsection-heading">Etiology</h3>
                        <ul>
                            <li><strong>diet (folate is present in leafy green vegetables)</strong>
                                <ul>
                                    <li>most common cause</li>
                                    <li>e.g. infancy, poverty, alcoholism</li>
                                </ul>
                            </li>
                             <li><strong>intestinal</strong>
                                <ul><li>malabsorption</li></ul>
                            </li>
                             <li><strong>drugs/chemicals</strong>
                                <ul>
                                    <li>alcohol</li>
                                    <li>anticonvulsants</li>
                                    <li>antifolates (MTX)</li>
                                    <li>birth control pills</li>
                                </ul>
                            </li>
                             <li><strong>increased demand</strong>
                                <ul>
                                    <li>pregnancy</li>
                                    <li>prematurity</li>
                                    <li>hemolysis</li>
                                    <li>hemodialysis</li>
                                    <li>psoriasis, exfoliative dermatitis</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Clinical Presentation</h3>
                        <ul>
                            <li>mildly jaundiced due to hemolysis of RBC secondary to ineffective hemoglobin synthesis</li>
                            <li>glossitis and angular stomatitis</li>
                            <li>rare
                                <ul>
                                    <li>melanin pigmentation</li>
                                    <li>purpura secondary to thrombocytopenia</li>
                                </ul>
                            </li>
                            <li>folate deficiency at time of conception and early pregnancy has been linked to neural tube defects</li>
                        </ul>
                        <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>never give folate alone to individual with megaloblastic anemia because it will mask B12 deficiency and neurological degeneration will continue</li>
                            <li>folic acid 15 mg PO/day x 3 months; then 5 mg PO/day maintenance if cause not reversible</li>
                            <li>folic acid supplementation 1 mg PO/day will protect against elevated homocysteine levels (risk factor for CAD)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: folate-deficiency -->
                
                 <!-- START: hemolytic-anemias -->
                <section id="hemolytic-anemias" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">HEMOLYTIC ANEMIAS (HA)</span>
                    </h2>
                    <div class="content-card">
                        <p>(see Colour Atlas H4)</p>
                        <h3 class="subsection-heading">Classification</h3>
                        <ul>
                            <li><strong>hereditary causes (intrinsic)</strong>
                                <ul>
                                    <li>abnormal membrane (spherocytosis, elliptocytosis)</li>
                                    <li>abnormal enzymes (pyruvate kinase deficiency, G6PD deficiency)</li>
                                    <li>abnormal hemoglobin synthesis (thalassemias, hemoglobinopathies)</li>
                                </ul>
                            </li>
                            <li><strong>acquired causes (extrinsic)</strong>
                                <ul>
                                    <li>immune
                                        <ul>
                                            <li>hemolytic transfusion reaction</li>
                                            <li>idiopathic immune HA</li>
                                            <li>drugs</li>
                                            <li>cold agglutinins</li>
                                            <li>secondary autoimmune HA</li>
                                        </ul>
                                    </li>
                                    <li>non-immune
                                        <ul>
                                            <li>RBC fragmentation syndromes</li>
                                            <li>paroxysmal nocturnal hemoglobinuria</li>
                                            <li>liver disease</li>
                                            <li>hypersplenism</li>
                                            <li>march hemoglobinuria</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Clinical Presentation</h3>
                        <ul>
                            <li>jaundice</li>
                            <li>cholelithiasis</li>
                            <li>splenomegaly</li>
                            <li>skeletal abnormalities</li>
                            <li>leg ulcers</li>
                            <li>regenerative crisis</li>
                            <li>folic acid deficiency</li>
                            <li>iron overload with extravascular hemolysis</li>
                            <li>iron deficiency with intravascular hemolysis</li>
                        </ul>
                        <h3 class="subsection-heading">Diagnosis</h3>
                        <ul>
                            <li><strong>indirect - not specific to hemolytic anemias</strong>
                                <ul>
                                    <li>increased reticulocyte count</li>
                                    <li>reduced haptoglobin</li>
                                    <li>increased unconjugated bilirubin</li>
                                    <li>increased urine bilinogen</li>
                                    <li>increased LDH</li>
                                </ul>
                            </li>
                            <li><strong>tests exclusive for intravascular hemolysis</strong>
                                <ul>
                                    <li>serum free hemoglobin present</li>
                                    <li>methemalbuminemia (heme + albumin)</li>
                                    <li>hemoglobinuria (immediate)</li>
                                    <li>hemosiderinuria (delayed)</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Antiglobulin Tests (Coombs' Tests)</h3>
                        <ul>
                            <li><strong>direct Coombs' test (direct antiglobulin test)</strong>
                                <ul>
                                    <li>purpose: detect antibodies or complement on the surface of RBC</li>
                                    <li>by adding anti-antibodies to the RBC; the RBC agglutinate in a positive test</li>
                                    <li>indications
                                        <ul>
                                            <li>hemolytic disease of newborn</li>
                                            <li>hemolytic anemia</li>
                                            <li>AIHA</li>
                                            <li>hemolytic transfusion reaction</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li><strong>indirect Coombs' test (indirect antiglobulin test)</strong>
                                <ul>
                                    <li>purpose: detect antibodies in serum that can recognize antigens on RBC</li>
                                    <li>by mixing serum with donor RBC and then anti-antibodies; RBCs agglutinate in a positive test</li>
                                    <li>indications
                                        <ul>
                                            <li>cross-matching of recipient serum with donor's RBC</li>
                                            <li>atypical blood group</li>
                                            <li>blood group antibodies in pregnant women</li>
                                            <li>antibodies in AIHA</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: hemolytic-anemias -->

                <!-- START: hereditary-hemolytic-anemias -->
                <section id="hereditary-hemolytic-anemias" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">I. HEREDITARY HEMOLYTIC ANEMIAS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">STRUCTURAL ABNORMALITIES IN CYTOSKELETON</h3>
                        <h4>Hereditary Spherocytosis</h4>
                        <ul>
                            <li>autosomal dominant with variable penetrance</li>
                            <li>incidence 22 per 100,000</li>
                            <li>most common type of hereditary hemolytic anemia</li>
                            <li>abnormality in spectrin (compound in RBC membrane)</li>
                            <li>blood film shows spherocytes (see Colour Atlas H8)</li>
                            <li>increased osmotic fragility</li>
                            <li>sometimes confused with immune hemolytic anemia</li>
                            <li>treatment: splenectomy (immunize against pneumococcus first); avoid in childhood</li>
                        </ul>
                        <h4>Hereditary Elliptocytosis</h4>
                        <ul>
                            <li>autosomal dominant</li>
                            <li>incidence 20-50 per 100,000</li>
                            <li>abnormality in spectrin interaction with other membrane proteins</li>
                            <li>25-75% elliptocytes</li>
                            <li>hemolysis is usually mild</li>
                            <li>treatment: splenectomy for severe hemolysis (immunize against pneumococcus first)</li>
                        </ul>

                        <h3 class="subsection-heading">ENZYMATIC ABNORMALITIES IN RBC</h3>
                        <h4>G6PD Deficiency</h4>
                        <h5>Clinical Presentation</h5>
                        <ul>
                            <li>X-linked recessive</li>
                            <li>oxidant drug-induced hemolysis
                                <ul>
                                    <li>sulfonamides</li>
                                    <li>primaquine</li>
                                    <li>nitrofurantoin</li>
                                    <li>acetanilid</li>
                                </ul>
                            </li>
                            <li>favism (fava beans)</li>
                            <li>neonatal jaundice</li>
                            <li>chronic hemolytic anemia</li>
                            <li>infection</li>
                        </ul>
                        <h5>Diagnosis and Management</h5>
                        <ul>
                            <li>high index of suspicion</li>
                            <li>G6PD assay
                                <ul><li>should not be done when reticulocyte count is high in acute crisis, PBF shows Heinz bodies (granules in red blood cells due to damaged hemoglobin molecules) and features of intravascular hemolysis</li></ul>
                            </li>
                            <li>transfusion in severe cases</li>
                            <li>stop offending drugs or food</li>
                        </ul>
                    </div>
                </section>
                <!-- END: hereditary-hemolytic-anemias -->

                <!-- START: acquired-hemolytic-anemias -->
                <section id="acquired-hemolytic-anemias" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">II. ACQUIRED HEMOLYTIC ANEMIAS</span>
                    </h2>
                    <div class="content-card">
                         <h3 class="subsection-heading">AUTOIMMUNE HEMOLYTIC ANEMIA</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 6. Classification of autoimmune hemolytic anemia</caption>
                                <thead>
                                    <tr><th></th><th>Warm</th><th>Cold</th></tr>
                                </thead>
                                <tbody>
                                    <tr><td>Antibody Coating RBC</td><td>- IgG</td><td>- IgM</td></tr>
                                    <tr><td>Temperature Detect by Coomb's</td><td>- 37°C</td><td>- 4-37°C</td></tr>
                                    <tr><td>Direct Coombs Test</td><td>- positive for antibodies</td><td>- positive for complement</td></tr>
                                    <tr><td>Etiology</td><td>- idiopathic<br>- secondary to lymphoproliferative disorder<br>- e.g. CLL, Hodgkin's<br>- secondary to autoimmune disease<br>- e.g. SLE<br>- drug induced<br>- penicillin<br>- quinine<br>- methyldopa</td><td>- idiopathic<br>- secondary to infection<br>- e.g. mycoplasma, EBV<br>- secondary to lymphoproliferative disorder<br>- e.g. macroglobulinemia, CLL</td></tr>
                                    <tr><td>Blood Film (see Colour Atlas H5)</td><td>- spherocytes</td><td>- agglutination</td></tr>
                                    <tr><td>Management</td><td>- treat underlying cause<br>- corticosteroids<br>- splenectomy<br>- immunosupression</td><td>- treat underlying cause<br>- warm patient<br>- plasmapheoresis<br>- immunosuppresion</td></tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: acquired-hemolytic-anemias -->

                <!-- START: rbc-fragmentation -->
                <section id="rbc-fragmentation" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">RBC FRAGMENTATION SYNDROMES</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Classification</h3>
                        <ul>
                            <li>cardiac and large vessel abnormalities (macroangiopathic)</li>
                            <li>small vessel disease (microangiopathic) (see Colour Atlas H7)
                                <ul>
                                    <li>thrombotic thrombocytopenic purpura (TTP)/ hemolytic uremic syndrome (HUS)</li>
                                    <li>DIC</li>
                                    <li>metastatic carcinoma</li>
                                    <li>eclampsia</li>
                                    <li>malignant hypertension</li>
                                    <li>vasculitis</li>
                                </ul>
                            </li>
                            <li>infection (malaria, clostridia)</li>
                            <li>drowning</li>
                            <li>thermal injury</li>
                        </ul>
                        <h3 class="subsection-heading">Diagnosis</h3>
                        <p>evidence of hemolysis, schistocytes, hemosiderinuria, hemoglobinuria</p>
                        <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>treat underlying disease, replace iron if indicated</li>
                        </ul>
                    </div>
                </section>
                <!-- END: rbc-fragmentation -->
                
                <!-- START: ttp-hus -->
                <section id="ttp-hus" class="content-section" aria-labelledby="section-heading-11">
                    <h2 id="section-heading-11" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC UREMIC SYNDROME</span>
                    </h2>
                     <div class="content-card">
                        <div class="table-container">
                             <table class="content-table">
                                <caption>Table 7. Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS)</caption>
                                <thead>
                                    <tr><th>TTP</th><th>HUS</th></tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>- <strong>predominantly adult</strong><br>- <strong>purpura (90%)</strong> due to severe thrombocytopenia<br>- epistaxis, hematuria, hemoptysis and GI bleed<br>- GI: N/V, abdominal pain<br>- renal (40-80%)<br>- etiology:<br>  - idiopathic<br>  - familial<br>  - secondary TTP<br>  - infection (enterobacteriaceae, viral: flu, HIV)<br>  - systemic diseases (SLE and other CVD)<br>  - cancer and chemotherapeutic drugs<br>- diagnosis:<br>  - by clinical picture<br>  - CBC: anemia, thrombocytopenia<br>  - PT, PTT: normal<br>  - ESR: normal<br>  - negative Coombs'</td>
                                        <td>- <strong>predominantly children</strong><br>- <strong>purpura (90-100%)</strong> due to severe thrombocytopenia<br>- <strong>microangiopathic hemolytic anemia</strong><br>- <strong>renal symptoms (90%)</strong><br>- etiology:<br>  - E. coli serotype O157:H7 virotoxin<br>- diagnosis:<br>  - by clinical picture<br>  - same as TTP<br>  - stool C+S</td>
                                    </tr>
                                    <tr>
                                        <td colspan="2">*Key characteristics bolded</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>plasmapheresis is the treatment of choice</li>
                            <li>steroid is treatment of choice only in mild disease</li>
                        </ul>
                    </div>
                </section>
                <!-- END: ttp-hus -->

                <!-- START: aplastic-anemia -->
                <section id="aplastic-anemia" class="content-section" aria-labelledby="section-heading-12">
                    <h2 id="section-heading-12" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">APLASTIC ANEMIA</span>
                    </h2>
                    <div class="content-card">
                        <p>destruction of hematopoietic cells of the bone marrow</p>
                        <h3 class="subsection-heading">Etiology</h3>
                        <ul>
                            <li>radiation</li>
                            <li>drugs
                                <ul>
                                    <li>anticipated (chemotherapy)</li>
                                    <li>idiosyncratic (chloramphenicol, phenylbutazone)</li>
                                </ul>
                            </li>
                            <li>chemicals
                                <ul>
                                    <li>benzene and other organic solvents</li>
                                    <li>DDT and insecticides</li>
                                </ul>
                            </li>
                            <li>post viral e.g. hepatitis B, parvovirus</li>
                            <li>idiopathic
                                <ul><li>often immune (T-cell mediated)</li></ul>
                            </li>
                            <li>paroxysmal nocturnal hemoglobinuria</li>
                            <li>marrow replacement</li>
                            <li>congenital</li>
                        </ul>
                        <h3 class="subsection-heading">Clinical Presentation</h3>
                        <ul>
                            <li>occurs at any age
                                <ul>
                                    <li>slightly more common in males</li>
                                    <li>can present acutely or insidiously</li>
                                </ul>
                            </li>
                            <li>anemia or neutropenia or thrombocytopenia (any combination) +/- pancytopenia</li>
                            <li>thrombocytopenia with bruising, bleeding gums, epistaxis</li>
                            <li>anemia with SOB, pallor and fatigue</li>
                            <li>presentation of neutropenia ranges from infection in the mouth to septicemia</li>
                            <li>absence of splenomegaly</li>
                        </ul>
                        <h3 class="subsection-heading">Diagnosis</h3>
                        <ul>
                             <li><strong>serum</strong>
                                <ul>
                                    <li>neutrophil count &lt;5.0 x 10<sup>9</sup>/L</li>
                                    <li>platelet count &lt;20 x 10<sup>9</sup>/L</li>
                                    <li>corrected reticulocyte count &lt; 1%</li>
                                </ul>
                            </li>
                            <li><strong>blood film</strong>
                                <ul><li>decreased normal RBC</li></ul>
                            </li>
                            <li><strong>bone marrow</strong>
                                <ul><li>aplasia or hypoplasia of marrow cells with fat replacement</li></ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Management</h3>
                        <ul>
                            <li>removal of offending agents</li>
                            <li>supportive care (red cell and platelet transfusions, antibiotics)</li>
                            <li>antithymocyte globulin (50-60% patients respond)</li>
                            <li>cyclosporine</li>
                            <li>allogeneic bone marrow transplantation
                                <ul>
                                    <li>minimize blood products on presentation</li>
                                    <li>only irradiated, leuko-depleted blood products should be used</li>
                                    <li>CMV negative blood for CMV negative patients</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: aplastic-anemia -->
            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hematology-introduction-anemia.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33.33%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 6</span> <!-- Update text -->
                    </div>
                    <a href="hematology-hemostasis-coagulation.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>